Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the launch of ScienceCloud, a new SaaS-based information management and collaboration workspace. ScienceCloud advances collaborative drug discovery with a new generation of integrated applications built on a scalable, cloud-based scientific platform. With no software to manage and no hardware to maintain, ScienceCloud improves operational excellence in globally networked research, significantly reducing IT cost and effort.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65595-sciencecloud-software-by-accelrys-advances-collaborative-drug-discovery
Le compte à rebours a commencé ! Lundi prochain, la Fondation L’Oréal, avec le soutien de L’Oréal France, la Commission française pour l’UNESCO et l’Académie des Sciences, récompensera 25 jeunes femmes scientifiques doctorantes. Elles ont été sélectionnées par un Jury présidé par Philippe Taquet, Président de l’Académie des sciences et composé de membres émérites de la communauté scientifique. Chacune d’entre elles a été distinguée pour la qualité et le fort potentiel de ses travaux de recherche. A l’occasion de la cérémonie de remise des Bourses L’Oréal France-UNESCO, ces jeunes femmes (26 ans en moyenne) recevront ainsi une bourse de 15 000 euros pour les soutenir dans leurs travaux et leur carrière scientifique, domaine où les femmes sont encore sous-représentées.
http://www.multivu.com/mnr/63470-loreal-france-unesco-femmes-science
The Dan David Prize award ceremony took place yesterday at Tel Aviv University, in the presence of Prof. Joseph Klafter, President of Tel Aviv University and Chairman of the Dan David Prize Board, Prof. Ruth Arnon, President of the Israel Academy of Sciences, members of the David family, the 2013 Dan David Prize laureates, foreign ambassadors, and prominent academic and business figures from Israel and abroad.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61910-dan-david-prizes-awarded
Phenogen Sciences, Inc. [www.phenogensciences.com] today announced the immediate availability of BREVAGen™, a predictive risk test for the millions of women at above average risk of developing estrogen-receptor positive breast cancer. This first-in-class, scientifically-validated risk assessment test examines a woman’s clinical risk factors, such as her lifetime exposure to estrogen, combined with scientifically validated genetic markers to determine each patient’s personalized five-year and lifetime risk of developing breast cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58399-phenogen-sciences-brevagen-breast-cancer-risk-assessment-test-availability
The American Transaction Processors Coalition (ATPC) formally launched today with a panel discussion in front of 400 industry employees, chamber of commerce executives, university leadership and elected officials from Congress, the Georgia General Assembly and local governments across metro Atlanta.
More than 40,000 employees work directly for 70-plus Georgia-based transaction processing companies within an area known as Transaction Alley. These companies generated more than $30 billion last year, far exceeding other well-known Georgia industries like life sciences at $17 billion or film at $3 billion. Transaction Alley revenues equal that of the entire U.S. movie industry, and is dominated by Atlanta, just as Los Angeles dominates films.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7081851-american-transaction-processors-coalition-launches-georgia-town-hall
People want to know—how do elite athletes prepare for their next fight, match, or race? It’s no surprise that athletes dedicate their lives to improving in their chosen sport, and many of them keep the same secret about how they maintain their craft at an elite level. But their secret is now out. It’s USANA Health Sciences.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7143551-usana-health-sciences-best-kept-secret-of-elite-athletes
There’s a lot more to Hollywood magic than smoke and mirrors – popular movie and TV shows about zombies, superheroes, spaceships and true crime only come to life because of science, technology, engineering and math (STEM).
That’s why Texas Instruments (TI) is launching “STEM Behind Hollywood,” an exciting new education program developed with assistance from The Science & Entertainment Exchange, a program of the National Academy of Sciences, as well as actress, neuroscientist and STEM education advocate Mayim Bialik.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54048-texas-instruments-stem-behind-hollywood-program-with-mayim-bialik
Aurora Flight Sciences announced today that the Defense Advanced Research Projects Agency (DARPA) has awarded the company the prime contract for Phase 2 of the Agency’s Vertical Takeoff and Landing Experimental Plane (VTOL X-Plane) program.
VTOL X-Plane seeks to develop a technology demonstrator that could:
• Achieve a top sustained flight speed of 300 kt-400 kt
• Raise aircraft hover efficiency from 60 percent to at least 75 percent
• Present a more favorable cruise lift-to-drag ratio of at least 10, up from 5-6
• Carry a useful load of at least 40 percent of the vehicle’s projected gross weight of 10,000-12,000 pounds
The Aurora team’s design for its unmanned aircraft, named LightningStrike, seeks to provide an approximately 50-percent increase in speed over existing VTOL aircraft designed for comparable mission applications.
To view the multimedia release go to:
http://www.multivu.com/players/English/7617851-aurora-flight-sciences-vtol-xplane-darpa/
Syneron Medical Ltd., the leading global aesthetic device company, announced to a group of international media its new activities and enhanced global commitment to developing the non-invasive body shaping market, one of the fastest growing segments in the global aesthetic medical device market. The press conference took place at the Academy of Medical Sciences in London, just prior to the opening of the BODY Conference and Exhibition, which took place in London on November 3-4, 2012 and for which Syneron was the main sponsor.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58631-body-shaping-by-syneron
George Freeman MP, the Minister for Life Sciences, will give the keynote address at the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
George Freeman’s keynote address will outline the Government’s aim to develop, assess and adopt new drugs, devices and diagnostics as we move towards 21st century, personalised healthcare.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7423951-george-freeman-astellas-debate/
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
Bright Starts™ introduces a fun new metric, the Baby Laugh Index™, in tandem with the launch of three new toys designed to inspire laughter. The inspirations for the focus on laughter are the three new baby toys from the Bright Starts Having a Ball™ collection: 3-in-1 Step ’N; Ride Lion™, Hide ’N Spin Monkey™ and Jungle Fun Ball Climber™. Teaming up with Gina Mireault, Ph.D. professor of psychology and counseling behavior sciences at Johnson State College and researcher of humor and emotional development in children, Bright Starts seeks to emphasize the importance of laughter in infant development.
To view the multimedia assets associated with this release, please click: http://www.multivu.com/players/English/7251151-bright-starts-tm-introduces-fun-new-baby-laugh-index/
